FDA approves Roche’s cobas EGFR Mutation Test v2 as CDx for NSCLC therapies
The cobas EGFR Mutation Test v2 is an FDA approved companion diagnostic for the detection of EGFR mutations…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Oct 20
The cobas EGFR Mutation Test v2 is an FDA approved companion diagnostic for the detection of EGFR mutations…
The future of US medical device markets may hinge on what Trump or Biden chooses to do regarding…
30 Oct 20
Through this partnership, Thermo Fisher will have the first option to produce new technologies developed by the TIC…
30 Oct 20
The study will assess the safety and efficacy of the WATCHMAN FLX LAAC device within a broad population…
30 Oct 20
Leveraging technology developed and licensed from ST, Alifax is manufacturing the Molecular Mouse, a small portable instrument that…
30 Oct 20
The FDA previously approved 1.5T and 3.0T MRI conditional labeling with head and full-body transmit coils for the…
30 Oct 20
The new consortium will use SARS-CoV-2 Direct Antigen Rapid Test (DART) test from E25Bio which provides results in…
30 Oct 20
The company intends to expand its end-to-end medical devices contract manufacturing business to nine locations
30 Oct 20
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare
30 Oct 20
IlluminOss Medical, Inc. is a privately held, commercial-stage medical device company offering a unique, minimally invasive technology for…